Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

"When results are published I hope Leo also makes it clear that B's anti-viral abilities doesn't stop at covid-19. "Brilacidin has shown potent and consistent inhibition in vitro against coronaviruses, alphaviruses, bunyaviruses and adenoviruses (with lab testing against other viruses also underway), supporting Brilacidin’s development as a broad-spectrum antiviral".

Sounds familiar. Hope it's not a rinse and repeat.

From Leo Ehrlich in the press release of May 24, 2016
"We had always wanted to explore Prurisol's clinical merit, as it had excellent results in laboratory studies. We put it to the test under some of the most demanding conditions, with respect to the IGA versus PASI scoring systems; short treatment duration; low dosing levels; enrollment that included patients who were previously treated with biologics; and evaluation in mild to moderate psoriasis patients, where it can be more difficult to achieve a meaningful therapeutic effect. To see such a strong response among patients, achieving clear to almost clear skin without serious side effects-the downside of biologics-in such a short period of time, is exceptional. We would like to thank patients and investigators who participated in the study. Prurisol has taken a key step towards potentially becoming only the second oral treatment approved by the FDA for psoriasis in decades."

https://seekingalpha.com/article/3979381-cellceutix-completes-successful-prurisol-phase-2-for-psoriasis